Would you like to receive important updates about Allergan PLC like earnings dates and more?
AGN Stock Price Today $172.76
Year To Date
The Year To Date (YTD) return is -20.09%.
52 Week Low
The 52 Week Low stock price is 160.07 set on Tue, Dec 5, 2017 which is 7 days ago.
The current price per share is 7.93% above the 52 week low.
52 Week High
The 52 Week High stock price is $256.80 set on Tue, Jul 25, 2017 which is 140 days ago.
The current price per share is -32.73% below the 52 week high.
All Time High
The All Time High stock price is $340.34 set on Wed, Jul 29, 2015 which is 867 days ago.
The current price per share is -49.24% below the all time high.
Allergan Stock Charts
5 Year Stock Chart
The Allergan 5 year stock chart shows the historical prices over the previous 60 months.
1 Year Stock Chart
The Allergan 1 year stock chart shows the historical prices over the previous 12 months.
50 Day Moving Average
The 50 Day Moving Average is at $239.37 which is 27.83% above the stock price of $172.76.
200 Day Moving Average
The 200 Day Moving Average is at 229.02 which is 24.57% above the stock price of $172.76.
Because both the 50 DMA and 200 DMA are above the current stock price, this can be considered a bearish technical indicator.
Since the stock price is very far from both moving averages, a price retracement towards the moving averages should not be unexpected.
AGN Company Profile
Allergan PLC is a Health Care stock that trades on the NYSE and has a market capitalization of $55.81 Billion.
Allergan plc is a specialty pharmaceutical company. The Company is engaged in the development, manufacturing, marketing and distribution of brand name pharmaceutical products, medical aesthetics, biosimilar and over-the-counter pharmaceutical products. The Company operates through three segments: US Specialized Therapeutics, US General Medicine and International. The US Specialized Therapeutics segment includes sales relating to branded products within the United States, including Medical Aesthetics, Medical Dermatology, Eye Care, Neurosciences and Urology therapeutic products. The US General Medicine segment includes sales relating to branded products within the United States that do not fall into the US Specialized Therapeutics business units, including Central Nervous System, Gastrointestinal, Women's Health, Anti-Infectives and Diversified Brands. The International segment includes sales relating to products sold outside the United States.
Below are several other Biotech & Pharma stocks include AbbVie Inc (ABBV), Allergan PLC (AGN), Alexion Pharmaceuticals Inc (ALXN), Amgen Inc (AMGN), Biogen Inc (BIIB), BioMarin Pharmaceutical Inc (BMRN), Bristol-Myers Squibb Co (BMY), Celgene Corp (CELG), Endo International PLC (ENDP), Gilead Sciences Inc (GILD), .
Earnings Per Share
The EPS is -$22.59 and the P/E Ratio is 0.
A negative Earnings Per Share (EPS) means that this company is losing money and not profitable at this time.
The Earnings Release Date was Thu, Aug 3, 2017.
Since this earnings release 131 days ago, the stock price is down by -30.95%.
Many investors know the importance of a companies earnings report. Also, the market reaction to the earnings release can be even more important and can help in making a prediction of a future price forecast of the shares.
A significant post earnings announcement percentage move can continue or reverse an existing trend for several days or weeks after the earnings date.
The most recent Earnings Release Date was on Wed, Nov 1, 2017, which was 41 days ago.
Since this earnings date, the stock price is down by -2.52%.
The Annual Dividend Yield is 1.62%.
Since the Ex-Date on Thu, Nov 16, 2017, 26 days ago, the stock price is down by -1.17%. (The next ex-dividend date will be around Wed, Feb 14, 2018.)
Dividend Pay Date
The Pay Date is Fri, Dec 15, 2017 which is in 3 days.
Investors should understand the dividend history of a company. Dividend history will show the dividend payments disbursed to investors over the years.